Search Ontology:
ChEBI
N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
- Term ID
- CHEBI:18259
- Synonyms
-
- (Gal)2 (GalNAc)1 (Glc)1 (Cer)1
- a globoside Gb4Cer (d18:1(4E))
- beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
- CTH/Gb4
- GalNAc-1->3-Gal-1->4-Gal-1->4-Glc-Cer
- GalNAcbeta1-3-Galalpha1-4Galbeta1-4Glcbeta1-1Cer
- Gb4 Globoside
- Gb4 Globotetraosyl ceramide
- Gb4Cer
- Gbose4Cer
- Globoside GL-4
- Globoside I
- Globotetraosyl ceramide
- N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
- N-acetyl-D-galactosaminyl-(1->3)-D-galactosyl-(1->4)-D-galactosyl-(1->4)-D-glucosylceramides
- N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide
- N-Acetyl-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide
- Slt-iiv receptor
- VT2vp1 Receptor
- Definition
- A glycotetraosylceramide having N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucose as the tetrasaccharide component.
- References
-
- cas:11034-93-8
- kegg.compound:C03272
- kegg.glycan:G00094
- pubmed:1528196
- pubmed:15495792
- pubmed:15661151
- pubmed:1601891
- pubmed:1724444
- pubmed:21252262
- pubmed:21376640
- pubmed:2448252
- pubmed:2456994
- pubmed:3220436
- pubmed:4026313
- pubmed:7287743
- pubmed:7690848
- pubmed:7691279
- pubmed:8161226
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Phenotype where environments contain N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Phenotype modified by environments containing N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Phenotype affecting N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Human Disease Model